International Graduates Face Growing Hurdles in Securing US Employment Hiring Slowdown and Immigration Shifts Challenge American Dream Microsoft and Anthropic Discuss Custom AI Chip Deal Amidst Strategic Investments US Advocacy Groups Call for Investigation into Robloxs Child Safety and Spending Practices Jobless Claims Remain Low Signaling Continued Labor Market Strength UK Exports to US Plunge 25 Following Trump Tariff Measures Amazons Growth Drivers Cloud Retail and Advertising Expansion DHCNI Q1 2026 Earnings EPS Misses Estimates Amid Healthcare Sector Headwinds SNN Q4 2014 Earnings Slight EPS Beat Meets Market Skepticism NXE Q1 2026 Earnings Heavy Losses No Revenue but Stock Edges Higher CLS Q1 2026 Earnings EPS Beat Fails to Lift Stock NextEra Energy NEE Q1 2026 Earnings EPS Beats Estimates by 125 as Renewable and Regulated Segments Drive Performance CNI Q1 2026 Earnings EPS Surpasses Estimates by 248 Stock Flat Gabelli Utility Trust GUT Faces Modest Decline Consolidates Between Key Support and Resistance AirSculpt Technologies AIRS Slides 25 as Shares Approach Key Support Level Pagaya Technologies Warrants PGYWW Climb 1255 as LowPriced Warrants Test Key 006 Level Duluth Holdings DLTH Jumps 43 as Stock Tests Critical Resistance Zone QXO Inc QXO Edges Higher as Stock Tests Key Resistance Zone Rail Vikas Nigam Q4 FY26 Net Profit Drops 59 Despite Revenue Growth Final Dividend Announced COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains Chewy CHWY Holds Steady at Range Midpoint Amid Low Volatility IMVT Q1 2026 Earnings EPS Misses Estimates Stock Slightly Positive Amid Development Progress MTRN Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Execution Investors Title Company ITIC Q4 2025 Earnings Strong EPS of 397 Amid Quiet Quarter The Kraft Heinz Company KHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Resilience GEOS Q1 2026 Earnings Reported Loss of 086 Per Share as Market Conditions Remain Pressured PLOW Q1 2026 Earnings Earnings Surge 161 Above Estimates as Profitability Surprises TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines